Pub. Date : 2014
PMID : 24803998
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | RESULTS: DFX treatment (20 mg/kg/day) significantly decreased serum ferritin level in patients with BTM; this was associated with a significant decrease in serum ALT, AST, ALP and increase in IGF-I concentrations. | Deferasirox | solute carrier family 17 member 5 | Homo sapiens |
| 2 | The use of DFX was associated with mild but significant reduction of ALT, AST and ALP and increase in IGF-I levels. | Deferasirox | solute carrier family 17 member 5 | Homo sapiens |